英国的医疗器械监管挑战正在影响创新及其潜在收益
Jacqueline Beddoe-Rosendo1, Clare L Heaysman1, Joseph V Hajnal1
1School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
概括
英国医疗技术创新受到越来越多的监管障碍的阻碍. 批准和通知机构的有限能力可能会促使公司寻求FDA对UKCA标记的批准,从而影响患者获得新疗法的机会.
科学领域:
- 生物医学工程 生物医学工程
- 监管科学 监管科学
- 卫生技术评估 卫生技术评估
背景情况:
- 英国医疗技术行业面临着不断升级的监管复杂性.
- 医疗技术的创新对于患者的治疗结果和经济增长至关重要.
- 现有的监管途径可能会构成进入市场的重大障碍.
研究的目的:
- 分析监管挑战对英国医疗技术创新的影响.
- 确定英国医疗器械监管框架中的特定瓶.
- 评估向替代监管途径的潜在转变,例如FDA批准.
主要方法:
- 对监管政策和行业反的定性分析.
- 评估英国认可和通知机构的能力和效率.
- 对UKCA标记与FDA批准流程的比较分析.
主要成果:
- 越来越多的监管挑战对英国的医疗技术创新产生了负面影响.
- 认可机构和通知机构的有限能力是造成重大障碍的重要障碍.
- 有一种潜在的趋势是寻求FDA批准而不是UKCA标记.
结论:
- 目前英国的监管环境可能会抑制医疗技术领域的创新.
- 解决监管机构的能力限制对于支持国内创新至关重要.
- 如果不适应监管流程,可能会限制患者获得在英国开发的尖端医疗技术.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Drug Control Governance: Regulatory Bodies and Their Impact
165
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
165
Bacterial Signaling
32.5K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
32.5K
Pharmacovigilance
863
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
863
Global Regulatory Systems
29
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
29


